Form 8-K - Current report:
SEC Accession No. 0001558370-22-009610
Filing Date
2022-06-01
Accepted
2022-06-01 16:00:57
Documents
12
Period of Report
2022-05-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K ampe-20220528x8k.htm   iXBRL 8-K 39260
  Complete submission text file 0001558370-22-009610.txt   157184

Data Files

Seq Description Document Type Size
2 EX-101.SCH ampe-20220528.xsd EX-101.SCH 3284
3 EX-101.LAB ampe-20220528_lab.xml EX-101.LAB 15365
4 EX-101.PRE ampe-20220528_pre.xml EX-101.PRE 10380
6 EXTRACTED XBRL INSTANCE DOCUMENT ampe-20220528x8k_htm.xml XML 4676
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

EIN.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35182 | Film No.: 22987256
SIC: 2834 Pharmaceutical Preparations